Kraig Labs Scales Transgenic Silkworm Production, Targets 10-Ton Monthly Output

  • Kraig Labs now producing over 10 metric tons of recombinant spider silk cocoons monthly, marking transition from development to industrial-scale production.
  • Company engaged with three major global brands for near-term deliveries of specialized spider silk materials.
  • First commercial-scale output from a transgenic animal platform producing a naturally spun, biodegradable structural material.
  • Deliveries to key customers expected in second half of 2026, representing significant milestone for materials science sector.

Kraig Labs' achievement represents a rare milestone in biotechnology, potentially becoming only the second company to commercialize products from transgenic animals. This breakthrough could transform materials science by offering a scalable, biodegradable alternative to traditional textiles. The company's ability to directly produce finished commercial material through the silkworm's native biological process sets it apart from prior transgenic efforts requiring extensive downstream manufacturing.

Commercial Viability
Whether Kraig Labs can sustain production at scale while meeting exacting customer specifications.
Market Adoption
The pace at which major brands integrate spider silk into flagship products.
Industry Precedent
How this achievement as the second company to commercialize transgenic animal products impacts biotech valuation.